Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Commentary: Cardiovascular disease (CVD) remains a leading cause of mortality globally,1 but with improved management, CVD is less fatal.2 However, this means a large proportion of the people are living with this long-term condition. As of 2015, 1 in 17 of the global population had CVD.3 There is lack of evidence across countries to truly quantify the significant economic consequences of this pressing global health issue.4 Overall, CVD is estimated to cost the European Union (EU) economy €210 billion a year: around 53% (€111 billion) due to healthcare costs, 26% (€54 billion) to productivity losses and 21% (€45 billion) to the informal care of people with CVD.5

More information Original publication

DOI

10.1177/2047487319850957

Type

Journal article

Journal

European Journal of Preventative Cardiology

Publisher

SAGE

Publication Date

15/05/2019

Addresses

Ralph Akyea: SPCR studentship